UTAH MEDICAL PRODUCTS INC

UTMD ·Healthcare, Medical Devices, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $85.8M $83.0M $92.9M $75.1M $61.0M $51.6M $42.8M $51.1M
Accounts Receivable $3.5M $4.1M $3.4M $5.5M $5.1M $4.1M $4.7M $4.0M
Inventory $7.9M $8.8M $9.6M $8.8M $6.6M $6.2M $6.9M $5.4M
Total Current Assets $97.7M $96.3M $106.3M $89.9M $73.2M $62.3M $54.9M $60.9M
Property, Plant & Equipment $9.9M $9.8M $10.6M $10.2M $10.6M $11.3M $10.7M $10.4M
Goodwill $14.1M $13.6M $13.7M $13.4M $14.1M $14.2M $14.0M $13.7M
Intangible Assets (Excl. Goodwill) $840.0K $2.9M $4.9M $10.4M $17.8M $24.0M $30.2M $14.8M
Total Assets $122.5M $122.5M $135.5M $123.9M $115.6M $111.7M $109.8M $99.8M
Liabilities
Accounts Payable $911.0K $696.0K $769.0K $1.2M $761.0K $788.0K $1.1M $975.0K
Total Current Liabilities $2.6M $3.8M $4.7M $6.0M $3.7M $3.8M $3.4M $5.3M
Long-Term Debt $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $3.3M $5.1M $7.1M $9.6M $8.5M $8.9M $8.7M $10.8M
Stockholders' Equity
Retained Earnings $128.7M $129.3M $138.3M $126.0M $115.3M $111.0M $110.8M $100.1M
Total Stockholders' Equity $119.3M $117.4M $128.3M $114.3M $107.1M $102.8M $101.1M $89.0M
← Newer Page 1 of 3 Older →